Glycation Isotopic Labeling with 13C-Reducing Sugars for Quantitative Analysis of Glycated Proteins in Human Plasma*
暂无分享,去创建一个
Alexander Scherl | Frédérique Lisacek | Markus Müller | Jean-Charles Sanchez | Feliciano Priego-Capote | Patrice Waridel | Markus Müller | F. Lisacek | Jean-Charles Sanchez | Alexander Scherl | F. Priego-Capote | P. Waridel
[1] P. Flatt,et al. Glycation of insulin results in reduced biological activity in mice , 1997, Acta Diabetologica.
[2] R. Appel,et al. On the benefits of acquiring peptide fragment ions at high measured mass accuracy , 2008, Journal of the American Society for Mass Spectrometry.
[3] K. Miedema. Towards worldwide standardisation of HbA1c determination , 2004, Diabetologia.
[4] L. Maillard,et al. Action des acides amines sur les sucres : formation des melanoidines par voie methodique , 1912 .
[5] Chris F. Taylor,et al. A common open representation of mass spectrometry data and its application to proteomics research , 2004, Nature Biotechnology.
[6] Richard D. Smith,et al. Analysis of non-enzymatically glycated peptides: neutral-loss-triggered MS(3) versus multi-stage activation tandem mass spectrometry. , 2008, Rapid communications in mass spectrometry : RCM.
[7] Paul J Thornalley,et al. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. , 1999, The Biochemical journal.
[8] P. Hoffmann,et al. Fragmentation behavior of glycated peptides derived from D-glucose, D-fructose and D-ribose in tandem mass spectrometry. , 2006, Journal of mass spectrometry : JMS.
[9] R. Flückiger,et al. Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites. , 1986, The Journal of biological chemistry.
[10] F. Pattou,et al. Glucotoxicity inhibits late steps of insulin exocytosis. , 2007, Endocrinology.
[11] R. Campbell,et al. Site specificity of glycation of horse liver alcohol dehydrogenase in vitro. , 1993, European journal of biochemistry.
[12] C. Calvo,et al. Non enzymatic glycation of apolipoprotein A-I. Effects on its self-association and lipid binding properties. , 1988, Biochemical and biophysical research communications.
[13] H. Chandalia,et al. Glycated Hemoglobin , 2020 .
[14] D. Goodlett,et al. Increasing information from shotgun proteomic data by accounting for misassigned precursor ion masses , 2008, Proteomics.
[15] J. Baynes,et al. The role of AGEs in aging: causation or correlation , 2001, Experimental Gerontology.
[16] Richard D. Smith,et al. Proteomic profiling of nonenzymatically glycated proteins in human plasma and erythrocyte membranes. , 2008, Journal of proteome research.
[17] G. Gill,et al. Protein glycosylation in diabetes mellitus: biochemical and clinical considerations , 2000 .
[18] Steven P Gygi,et al. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry , 2007, Nature Methods.
[19] I. Jerić,et al. Tracing glycoprotein structures: electrospray ionization tandem mass spectrometric analysis of sugar-peptide adducts. , 2002, Journal of mass spectrometry : JMS.
[20] M. Mann,et al. Higher-energy C-trap dissociation for peptide modification analysis , 2007, Nature Methods.
[21] R. Kalyani,et al. Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. , 2006, JAMA.
[22] A. Hipkiss,et al. Accumulation of altered proteins and ageing: Causes and effects , 2006, Experimental Gerontology.
[23] T. Metz,et al. Proteomic analysis of the site specificity of glycation and carboxymethylation of ribonuclease. , 2003, Journal of proteome research.
[24] J. Baynes,et al. The Amadori product on protein: structure and reactions. , 1989, Progress in clinical and biological research.
[25] M. Brownlee. Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.
[26] H. Kaneto,et al. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. , 2008, Endocrine journal.
[27] J. Cipollo,et al. A glycomics platform for the analysis of permethylated oligosaccharide alditols , 2007, Journal of the American Society for Mass Spectrometry.
[28] Lukas N. Mueller,et al. SuperHirn – a novel tool for high resolution LC‐MS‐based peptide/protein profiling , 2007, Proteomics.
[29] C. Calvo,et al. Association in Vivo of Glycated Apolipoprotein A-I with High Density Lipoproteins , 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[30] Qibin Zhang,et al. A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease. , 2009, Journal of proteome research.
[31] D. Leroith. Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities. , 2002, The American journal of medicine.
[32] K. Baynes,et al. Artefactually low glycated haemoglobin is a potential pitfall in diabetes management: consider congenital haemolytic anaemias , 2001 .
[33] S. Brunak,et al. Analysis and prediction of mammalian protein glycation. , 2006, Glycobiology.
[34] A. Ohnishi,et al. Structural and glycation site changes of albumin in diabetic patient with very high glycated albumin. , 2007, Clinica chimica acta; international journal of clinical chemistry.
[35] A. Cerami,et al. Protein glycation, diabetes, and aging. , 2001, Recent progress in hormone research.
[36] J. Reusch,et al. Diabetes, microvascular complications, and cardiovascular complications: what is it about glucose? , 2003, The Journal of clinical investigation.
[37] C. Calvo,et al. Characterization of the non enzymatic glycation of high density lipoprotein in diabetic patients. , 1988, Diabete & metabolisme.
[38] A. Goldfine,et al. Molecular basis for a link between complement and the vascular complications of diabetes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[39] Michael Brownlee,et al. Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. , 2006, JAMA.
[40] Jean-Charles Sanchez,et al. Glucotoxicity and pancreatic proteomics. , 2009, Journal of proteomics.
[41] J. Wojcicki,et al. Validation of Hemoglobin Glycation Models Using Glycemia Monitoring In Vivo and Culturing of Erythrocytes In Vitro , 2008, Annals of Biomedical Engineering.
[42] M. Mann,et al. Precision proteomics: The case for high resolution and high mass accuracy , 2008, Proceedings of the National Academy of Sciences.
[43] M. Mann,et al. Global and site-specific quantitative phosphoproteomics: principles and applications. , 2009, Annual review of pharmacology and toxicology.